Open label, phase II randomized study of oral valganciclovir versus valacyclovir for prophylaxis of cytomegalovirus reactivation in patients receiving alemtuzumab (Campath)
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Valganciclovir (Primary) ; Valaciclovir
- Indications Cytomegalovirus infections
- Focus Therapeutic Use
- 13 Dec 2007 New trial record.